WebCSL: Lowering target price to $226.00 CARLISLE COS INC has an Investment Rating of BUY; a target price of $226.000000; an Industry Subrating of High; a Management … Discover historical prices for CSL stock on Yahoo Finance. View daily, weekly or … Find the latest Carlisle Companies Incorporated (CSL) stock discussion in … See Carlisle Companies Incorporated (CSL) stock analyst estimates, including … See the company profile for Carlisle Companies Incorporated (CSL) … Find out all the key statistics for Carlisle Companies Incorporated (CSL), … Get the detailed quarterly/annual income statement for Carlisle Companies … See Carlisle Companies Incorporated (CSL) Environment, Social and Governance … Interactive Chart for Carlisle Companies Incorporated (CSL), analyze all the data … View the basic CSL option chain and compare options of Carlisle Companies … Find out the direct holders, institutional holders and mutual fund holders for … WebCSL's Investor Relations Center. Here you will find information relating to Financial Results, Financial Calendar, Annual Reports and other Shareholder-related information.
Share Price CSL Limited
WebApr 10, 2024 · Using the 2 Stage Free Cash Flow to Equity, CSL fair value estimate is AU$295. With AU$300 share price, CSL appears to be trading close to its estimated fair value. The US$344 analyst price target ... shortcut for next email in outlook
CSL Limited (CSLLY) Stock Price, News, Quote & History - Yahoo …
WebApr 12, 2024 · Zacks Rank and Stocks to Consider. CSL currently carries a Zacks Rank #4 (Sell). Some better-ranked companies are discussed below. Deere & Company DE presently sports a Zacks Rank #1 (Strong Buy ... WebYahoo Finance AU. Coles and Flybuys drop instant discounts. Coles and Flybuys are offering discounts to members throughout November. Shoppers can save up to $10 on these grocery items. Yahoo Finance AU. Surprising reason Coles, Woolies shoppers spend an extra $70 despite price hikes. Web2 days ago · NEW YORK, April 12, 2024 /PRNewswire/ -- The plasma protease C1 inhibitor market size is forecasted to increase by USD 1.7 billion from 2024 to 2026, at a CAGR of 7.4%, according to the recent ... shortcut for new tab in edge